Report Feature
The future of the global molecular cytogenetic market looks promising with opportunities in applications, such as genetic disorders, cancer, and personalized medicine. The global molecular cytogenetic market is expected to grow with a CAGR of 9%-11% from 2020 to 2025. The major drivers for this market are increasing incidence of genetic disorders & cancer and growing focus on targeted cancer treatment.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global molecular cytogenetic market report, please download the report brochure.
In this market, kits and reagents is the fastest growing product of molecular cytogenetics, whereas clinical and research laboratories is the fastest growing end user. Growth in various segments of the molecular cytogenetics market are given below:
The study includes trends and forecast for the global molecular cytogenetic market by product, technique, end user, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Kits & Reagents
- Testing Kits
- Probes
- Fluorescent Affinity Reagents
- Other Kits & Reagents
- Instruments
- Consumables
- Software & Services
By Technique [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Comparative Genomic Hybridization
- Array-Based Comparative Genomic Hybridization
- Standard Comparative Genomic Hybridization
- Fluorescence in Situ Hybridization
- In Situ Hybridization
- Other Techniques
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Genetic Disorders
- Cancer
- Personalized Medicine
- Other Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Clinical & Research Laboratories
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- Spain
- Italy
- France
-
Asia Pacific
- China
- Japan
- India
-
The Rest of the World
- Brazil
Some of the molecular cytogenetics companies profiled in this report include Roche, Danaher, Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Illumina.
Lucintel forecasts that kits and reagents will remain the largest product segment over the forecast period due to the increasing incidence of genetic disorders and cancer.
Within this market, clinical and research laboratories will remain the largest end user segment over the forecast period due to the growing implementation of cytogenetic techniques in clinical diagnosis.
North America will remain the largest region over the forecast period due to the local presence of major entities, such as Agilent Technologies and Abbott Laboratories. Moreover, the presence of an effective regulatory framework for the regulation of genetic tests in the region acts as a growth booster for the North American molecular cytogenetic market.
|
Features of the Global Molecular Cytogenetic Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global molecular cytogenetic market by product (kits & reagents (testing kits, probes, fluorescent affinity reagents, and other kits & reagents), instruments, consumables, and software & services), technique (comparative genomic hybridization (array-based comparative genomic hybridization and standard comparative genomic hybridization), fluorescence in situ hybridization, in situ hybridization, and other techniques), application (genetic disorders, cancer, personalized medicine, and other applications), end user (clinical & research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global molecular cytogenetic market? Q.5 What are the business risks and threats to the global molecular cytogenetic market? Q.6 What are the emerging trends in this molecular cytogenetic market and the reasons behind them? Q.7 What are some changing demands of customers in this molecular cytogenetic market? Q.8 What are the new developments in this molecular cytogenetic market? Which companies are leading these developments? Q.9 Who are the major players in this molecular cytogenetic market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this molecular cytogenetic market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global molecular cytogenetic market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Kits & Reagents (Testing Kits, Probes, Fluorescent Affinity Reagents, and Other Kits & Reagents), Instruments, Consumables, and Software & Services), Technique (Comparative Genomic Hybridization (Array-Based Comparative Genomic Hybridization and Standard Comparative Genomic Hybridization), Fluorescence In Situ Hybridization, In Situ Hybridization, and Other Techniques), Application (Genetic Disorders, Cancer, Personalized Medicine, and Other Applications), and End User (Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (Germany, United Kingdom, Spain, Italy, and France), Asia (China, Japan, and India), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Molecular Cytogenetic Market
4.1 Global Molecular Cytogenetic Market by Region
4.2.1 Market by Product: Kits & Reagents (Testing Kits, Probes, Fluorescent Affinity Reagents, and Other Kits & Reagents), Instruments, Consumables, and Software & Services
4.2.2 Market by Technique: Comparative Genomic Hybridization (Array-Based Comparative Genomic Hybridization and Standard Comparative Genomic Hybridization), Fluorescence In Situ Hybridization, In Situ Hybridization, and Other Techniques
4.2.3 Market by Application: Genetic disorders, Cancer, Personalized Medicine, and Other Applications
4.2.4 Market by End User: Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, and Other End Users
4.2.5 The United States Molecular Cytogenetic Market
4.2.6 The Canadian Molecular Cytogenetic Market
4.2.7 The Mexican Molecular Cytogenetic Market
4.3.1 Market by Product: Kits & Reagents (Testing Kits, Probes, Fluorescent Affinity Reagents, and Other Kits & Reagents), Instruments, Consumables, and Software & Services
4.3.2 Market by Technique: Comparative Genomic Hybridization (Array-Based Comparative Genomic Hybridization and Standard Comparative Genomic Hybridization), Fluorescence In Situ Hybridization, In Situ Hybridization, and Other Techniques
4.3.3 Market by Application: Genetic disorders, Cancer, Personalized Medicine, and Other Applications
4.3.4 Market by End User: Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, and Other End Users
4.3.5 The German Molecular Cytogenetic Market
4.3.6 The United Kingdom Molecular Cytogenetic Market
4.3.7 The Spain Molecular Cytogenetic Market
4.3.8 The Italy Molecular Cytogenetic Market
4.3.9 The French Molecular Cytogenetic Market
4.4.1 Market by Product: Kits & Reagents (Testing Kits, Probes, Fluorescent Affinity Reagents, and Other Kits & Reagents), Instruments, Consumables, and Software & Services
4.4.2 Market by Technique: Comparative Genomic Hybridization (Array-Based Comparative Genomic Hybridization and Standard Comparative Genomic Hybridization), Fluorescence In Situ Hybridization, In Situ Hybridization, and Other Techniques
4.4.3 Market by Application: Genetic disorders, Cancer, Personalized Medicine, and Other Applications
4.4.4 Market by End User: Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, and Other End Users
4.4.5 The Chinese Molecular Cytogenetic Market
4.4.6 The Indian Molecular Cytogenetic Market
4.4.7 The Japanese Molecular Cytogenetic Market
4.5.1 Market by Product: Kits & Reagents (Testing Kits, Probes, Fluorescent Affinity Reagents, and Other Kits & Reagents), Instruments, Consumables, and Software & Services
4.5.2 Market by Technique: Comparative Genomic Hybridization (Array-Based Comparative Genomic Hybridization and Standard Comparative Genomic Hybridization), Fluorescence In Situ Hybridization, In Situ Hybridization, and Other Techniques
4.5.3 Market by Application: Genetic disorders, Cancer, Personalized Medicine, and Other Applications
4.5.4 Market by End User: Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, and Other End Users
4.5.5 Brazilian Molecular Cytogenetic Market
7.1.1 Growth Opportunities for the Global Molecular Cytogenetic Market by Product
7.1.2 Growth Opportunities for the Global Molecular Cytogenetic Market by Application
7.1.3 Growth Opportunities for the Global Molecular Cytogenetic Market by End User
7.1.4 Growth Opportunities for the Global Molecular Cytogenetic Market by Application
7.1.5 Growth Opportunities for the Global Molecular Cytogenetic Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
